Patient-centric best practices for operating genetics and high-risk cancer programs in the age of COVID-19.
Limiting access to care might reduce the risk of contracting the novel coronavirus, but at the same time increases the risk of spiking late-stage...
Best Practices from CancerIQ partners engaging patients in virtual genetics and high-risk programs amidst a pandemic.
Fewer Americans have been getting cancer screenings since COVID-19 restrictions were put into place. To address concerns, Dr. Westgate and her team...
CancerIQ addresses many of the concerns that are top of mind for the 55 cancer programs Advisory Board surveyed to see how COVID-19 has changed their...
Why it is vital to keep genetics programs active during COVID-19 shutdowns and how virtual screenings can keep us ahead of cancer.
Switching from in-person visits to phone/video calls can feel a little bit daunting. To help your transition, we met with our client Dignity Health...
Leverage CancerIQ to deliver Telehealth Services Over the Next 90 Days
CancerIQ helped CHRISTUS identify more high-risk cancer patients, generating downstream revenue while improving care.
At the HIMSS 2020 conference, join Dr. Candace Westgate and Dr. Zanone for a presentation on identifying and managing patients at risk for cancer...